ew of the pathogenesis of cardiovascular complications secondary to COVID-19 and focus on the mechanisms that may contribute to the likely benefits of n-3 PUFAs and their metabolites.

1  Introduction
The first outbreak of the novel coronaviruses was triggered by severe and acute